Skip to main content
Clinical Trials/IRCT20200608047701N1
IRCT20200608047701N1
Not yet recruiting
Phase 2

The effect of Selenium supplementation on clinical outcomes of Preeclampsia, metabolic profiles, and Pulsatility Index (PI ) of uterine artery in Doppler sonography in high risk mothers screening with Quadruple tests

Kashan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Kashan University of Medical Sciences
Enrollment
60
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • High\-risk pregnant women for pre\-eclampsia screened with Quadruple tests
  • Age of 18 to 40
  • Pregnant woman living in Kashan
  • First pregnancy
  • Single pregnancy
  • Lack of bone and chromosomal abnormalities
  • Complete the consent form

Exclusion Criteria

  • Lack of willingness to cooperate at any stage of the project
  • Under age of 18 years old
  • Pregnant women who are currently smoking (Low risk for preeclampsia )
  • Pregnant women who are taking selenium supplements
  • Pregnant women who are taking thyroid medication
  • Pregnant women who are taking Aspirin , Heparin or Anti hypertensive drugs
  • Pregnant women who have chronic proteinuria
  • Abnormal scan anomalies

Outcomes

Primary Outcomes

Not specified

Similar Trials